Arkolith/Insider Trading/CKPT/Form 4

Oliviero James F III

CEO, President and Director, DirectorCheckpoint Therapeutics, Inc. (CKPT) · full profile →Form 4 · filed Dec 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.1M
Net Open-Market Flow
-$3.1M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 20, 2024Gift(G)900K—$02.3M
Dec 19, 2024Sell(S)220K$3.38$744K3.2M
Dec 18, 2024Sell(S)602K$3.87$2.3M3.4M

Transaction Codes

G
Gift
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-130963) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML